Deleterious germline mutations in BRCA2 may confer up to 84% risk of breast cancer and 27% risk of ovarian cancer in women, and are frequently associated with Ashkenazi Jewish decent (Am. J. Hum. This evidence concerns the gene BRCA2 and breast carcinoma.